17-(1H-benzimidazol-1-yl)androsta-5,16-dien-3beta-ol,
3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene,
galeterone,
VN-124-1,
Galeterone,
TOK-001,
851983-85-2,
VN/124-1,
UNII-WA33E149SW,
TOK 001,
VN/124,
WA33E149SW,
(3beta)-17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3-ol,
(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol,
Galeterone [USAN:INN],
VN 124,
Galeterone (USAN),
galeterone-tok-001,
VN-124-1,
TOK-001(Galeterone),
TOK-001; Galeterone,
Tok-001 (galeterone),
SCHEMBL939234,
GTPL8638,
17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3beta-ol,
CHEMBL2105738,
Galeterone, >=98% (HPLC),
3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene,
PAFKTGFSEFKSQG-PAASFTFBSA-N,
(3?)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol,
3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene,
BCPP000040,
BCP02827,
EX-A1025,
TOK-001/,
ZINC6718442,
ABP000369,
BDBM50435990,
MFCD16660907,
AKOS005146524,
CM11049,
CS-0334,
DB12415,
RL05280,
AC-26549,
HY-70006,
SC-96681,
Y0281,
D10125,
W-5660,
J-501178,
3beta-Hydroxy-17-(1H-benzimidazol-1-yl)-androsta-5,16-diene,
3beta-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene,
Androsta-5,16-dien-3-ol, 17-(1H-benzimidazol-1-yl)-, (3beta)-,
(3S,8R,9S,10R,13S,14S)-17-(1H-Benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol,
Galaterone,
Galeterone [USAN],
TOK-OO1,
D0U0BU,
cc-264,
C26H32N2O,
CID11188409,
CID 11188409,
A8623,
C500627,
C570636,
(3alpha,8alpha)-17-(1h-Benzimidazol-1-Yl)androsta-5,16-Dien-3-Ol,